FULC logo

Fulcrum Therapeutics (FULC)

Profile

Full Name

Fulcrum Therapeutics, Inc.

Ticker Symbol

FULC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 18, 2019

Indexes

Not included

Website

http://www.fulcrumtx.com

Employees

45

Key Details

Price

$2.92(+8.55%)

Market cap

$157.62M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$80.00M(+2752.05% YoY)

Annual EPS

-$0.16(+89.94% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.92
FULC price is $2.92

30-Day Relative Volume

0.69
FULC 30-day relative volume is 0.69

Price Performance

Price Most recent change

+8.55%
FULC price was up +8.55% on Apr 14, 2025

Price YTD change

-37.87%
FULC price is down -37.87% since January 1st

Price 1-year change

-61.07%
FULC price is down -61.07% year-on-year

Price 3-year change

-77.95%
FULC price is down -77.95% over the past 3 years

Price Range

Price All-time high

$33.10
FULC price is currently -91.18% below its historical high of $33.10

Price 3-year low

$2.25
FULC price is currently +29.78% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$157.62M
FULC market capitalization is $157.62 million

Market cap 3-year change

-70.83%
FULC market capitalization is down -70.83% over the past 3 years

Market cap All-time high

$1.25B
FULC market capitalization is currently -87.37% below its historical high of $1.25 billion

Market cap sector rank

54.44%
FULC market capitalization is higher than 54.44% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-13.13%
FULC shares outstanding is down -13.13% year-on-year

Shares Outstanding 3-Year Change

+32.24%
FULC shares outstanding is up +32.24% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.34
FULC beta is 1.34

200-day SMA

$4.85
FULC price is currently -39.85% below its 200-day simple moving average

50-day SMA

$3.24
FULC price is currently -9.82% below its 50-day simple moving average

RSI

48.97
FULC 14-day relative strength index is 48.97

Volume

0.69
FULC 30-day relative volume is 0.69

ATR

$0.24
FULC average true range is $0.24

10-day Historical Volatility

111.21%
FULC 10-day historical volatility is 111.21%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$80.00M
FULC annual revenue is $80.00 million

Revenue Analysts estimate

-
FULC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+2752.05%
FULC annual revenue is up +2752.05% year-on-year

Revenue Sector rank

53.42%
FULC annual revenue is higher than 53.42% of companies in Healthcare sector

EPS

EPS

-$0.16
FULC annual earnings per share is -$0.16

EPS Analysts estimate

-$1.25
FULC annual earnings per share is currently -87.20% lower than the consensus analysts' forecast

EPS 1-year change

+89.94%
FULC annual earnings per share is up +89.94% year-on-year

EPS Sector rank

79.16%
FULC annual earnings per share is higher than 79.16% of companies in Healthcare sector

Profit

Gross profit

-
FULC annual gross profit value is unknown

Gross margin

-
FULC annual gross profit margin value is unknown

Operating profit

-$19.83M
FULC annual operating income is -$19.83 million

Operating margin

-24.79%
FULC annual operating profit margin is -24.79%

Net income

-$9.72M
FULC annual net profit is -$9.72 million

Net margin

-12.16%
FULC annual net profit margin is -12.16%

Expenses

Total expenses

$99.83M
FULC annual total expenses is $99.83 million

Operating expenses

$99.83M
FULC annual total operating expenses is $99.83 million

Cost of goods sold

-
FULC annual cost of goods sold value is unknown

Selling, general & administrative expenses

$36.45M
FULC annual SGA is $36.45 million

Depreciation and amortization

$1.59M
FULC annual depreciation & amortization is $1.59 million

Interest expense

-
FULC annual interest expense value is unknown

Income tax

-
FULC annual income tax value is unknown

EBIT & EBITDA

EBIT

-$19.83M
FULC annual earnings before interest & taxes is -$19.83 million

EBITDA

-$18.24M
FULC annual EBITDA is -$18.24 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$260.72M
FULC annual total assets is $260.72 million

Non current assets

$10.79M
FULC annual long term assets is $10.79 million

Current assets

$249.92M
FULC annual total current assets is $249.92 million

Cash and cash equivalents

$58.21M
FULC annual cash & cash equivalents is $58.21 million

Accounts receivable

-
FULC annual accounts receivable value is unknown

Inventory

-
FULC annual inventory value is unknown

Liabilities

Total liabilities

$17.68M
FULC annual total liabilities is $17.68 million

Long term liabilities

$6.64M
FULC annual total long term liabilities is $6.64 million

Current liabilities

$11.04M
FULC annual total current liabilities is $11.04 million

Accounts payable

$1.16M
FULC annual accounts payable is $1.16 million

Debt

Total debt

$8.63M
FULC annual total debt is $8.63 million

Total debt 1-year change

-20.26%
FULC annual total debt is down -20.26% year-on-year

Long term debt

$6.44M
FULC annual long term debt is $6.44 million

Short term debt

$2.19M
FULC annual short term debt is $2.19 million

Equity & Capital

Shareholders equity

$243.03M
FULC annual stockholders equity is $243.03 million

Book value

$243.03M
FULC annual book value is $243.03 million

Retained earnings

-$519.40M
FULC annual retained earnings is -$519.40 million

Working capital

$238.88M
FULC annual working capital is $238.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$2.22M
FULC annual cash flow from operations is -$2.22 million

Cash from operations 1-year change

+97.56%
FULC annual cash flow from operations is up +97.56% year-on-year

Cash from investing

$32.23M
FULC annual cash flow from investing activities is $32.23 million

Cash from investing 1-year change

+187.84%
FULC annual cash flow from investing activities is up +187.84% year-on-year

Cash from financing

$2.75M
FULC annual cash flow from financing activities is $2.75 million

Cash from financing 1-year change

-97.68%
FULC annual cash flow from financing activities is down -97.68% year-on-year

CAPEX

CAPEX

$278.00K
FULC annual capital expenditures is $278.00 thousand

CAPEX 1-year change

-45.28%
FULC annual capital expenditures is down -45.28% year-on-year

Free Cash Flow

Free cash flow

-$2.50M
FULC annual free cash flow is -$2.50 million

Free cash flow 1-year change

+97.27%
FULC annual free cash flow is up +97.27% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
FULC annual gross profit margin value is unknown

Operating margin

-24.79%
FULC annual operating profit margin is -24.79%

Net margin

-12.16%
FULC annual net profit margin is -12.16%

ROA & ROE

ROA

-3.75%
FULC annual return on assets is -3.75%

ROE

-4.07%
FULC annual return on equity is -4.07%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
FULC price to earnings ratio value is unknown

PE ratio Sector rank

-
FULC price to earnings ratio is unknown

PB Ratio

PB ratio

0.65
FULC price to book ratio is 0.65

PB ratio Sector rank

34.73%
FULC price to book ratio is higher than 34.73% of companies in Healthcare sector

PS Ratio

PS ratio

-
FULC price to sales ratio value is unknown

PS ratio Sector rank

-
FULC price to sales ratio is unknown

Enterprise value

Enterprise value

$108.04M
FULC enterprise value is $108.04 million

Enterprise value Sector rank

51.4%
FULC enterprise value is higher than 51.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.92
FULC EV/EBITDA is -5.92

EV/EBITDA Sector rank

16.61%
FULC EV/EBITDA is higher than 16.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

22.63
FULC annual current ratio is 22.63

Quick ratio

-
FULC annual quick ratio value is unknown

Leverage

Debt to equity

0.00
FULC annual debt to equity ratio is 0.00

Interest coverage ratio

-
FULC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
FULC piotroski f-score value is unknown

Altman Z-Score

3.71
FULC altman z-score is 3.71

Analyst ratings

Recent major analysts updates

Feb 26, 25 HC Wainwright & Co.
Neutral
Nov 14, 24 RBC Capital
Sector Perform
Nov 14, 24 HC Wainwright & Co.
Neutral
Sep 13, 24 RBC Capital
Sector Perform
Sep 13, 24 HC Wainwright & Co.
Neutral
Sep 12, 24 Stifel
Hold
Sep 12, 24 Leerink Partners
Market Perform
Sep 12, 24 Cantor Fitzgerald
Neutral
Sep 12, 24 B of A Securities
Underperform
Sep 9, 24 B of A Securities
Neutral

Institutional Ownership

Similar stocks

NBTX logo
Nanobiotix SA (NBTX)
BWAY logo
BrainsWay (BWAY)
Actuate Therapeutics (ACTU)
MASS logo
908 Devices (MASS)
IPHA logo
Innate Pharma SA (IPHA)
JYNT logo
Joint (JYNT)
RZLT logo
Rezolute (RZLT)
ARAY logo
Accuray Incorporated (ARAY)
CGC logo
Canopy Growth (CGC)
  • What is the ticker symbol for Fulcrum Therapeutics?
  • Does Fulcrum Therapeutics pay dividends?
  • What sector is Fulcrum Therapeutics in?
  • What industry is Fulcrum Therapeutics in?
  • What country is Fulcrum Therapeutics based in?
  • When did Fulcrum Therapeutics go public?
  • Is Fulcrum Therapeutics in the S&P 500?
  • Is Fulcrum Therapeutics in the NASDAQ 100?
  • Is Fulcrum Therapeutics in the Dow Jones?
  • When was Fulcrum Therapeutics's last earnings report?
  • When does Fulcrum Therapeutics report earnings?
  • Should I buy Fulcrum Therapeutics stock now?

What is the ticker symbol for Fulcrum Therapeutics?

The ticker symbol for Fulcrum Therapeutics is NASDAQ:FULC

Does Fulcrum Therapeutics pay dividends?

No, Fulcrum Therapeutics does not pay dividends

What sector is Fulcrum Therapeutics in?

Fulcrum Therapeutics is in the Healthcare sector

What industry is Fulcrum Therapeutics in?

Fulcrum Therapeutics is in the Biotechnology industry

What country is Fulcrum Therapeutics based in?

Fulcrum Therapeutics is headquartered in United States

When did Fulcrum Therapeutics go public?

Fulcrum Therapeutics's initial public offering (IPO) was on July 18, 2019

Is Fulcrum Therapeutics in the S&P 500?

No, Fulcrum Therapeutics is not included in the S&P 500 index

Is Fulcrum Therapeutics in the NASDAQ 100?

No, Fulcrum Therapeutics is not included in the NASDAQ 100 index

Is Fulcrum Therapeutics in the Dow Jones?

No, Fulcrum Therapeutics is not included in the Dow Jones index

When was Fulcrum Therapeutics's last earnings report?

Fulcrum Therapeutics's most recent earnings report was on Feb 25, 2025

When does Fulcrum Therapeutics report earnings?

The next expected earnings date for Fulcrum Therapeutics is May 13, 2025

Should I buy Fulcrum Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page